Background: Some studies suggest that female practitioners are more likely to provide guideline-concordant care than male practitioners; however, little is known about the role of practitioner gender in cardiology. Objective: The aim of the study was to measure the association between practitioner gender and adherence to the cardiovascular performance measures in the American College of Cardiology"s ambulatory Practice Innovation and Clinical Excellence Registry. Methods: Patients with at least 1 outpatient visit with a unique practitioner were included. Among eligible patients, adherence to 7 guideline-supported performance measures for coronary artery disease, heart failure, and atrial fibrillation over 12 months after registry entry was compared by practitioner gender using hierarchical models adjusting for practitioner type (physicians vs advance practice practitioners) and number of visits. Results: The study cohort included 1493 individual practitioners who saw 769 139 patients; 80% of practitioners were men. Male practitioners were more often physicians compared with female practitioners (98.2% vs 43.7%, P G .01). Accounting for practitioner category and visit frequency, guideline adherence rates were similar by practitioner gender for all measures with the exception of marginally higher rates for coronary artery disease performance measures for male practitioners compared with female practitioners (antiplatelet: rate ratio [RR] = 1.06; 95% confidence interval [CI], 1.03Y1.09; "-blockers: RR = 1.06; 95% CI, 1.01Y1.10; and lipid-lowering drug: RR = 1.07; 95% CI, 1.04Y1.10) and atrial fibrillation (oral anticoagulants: RR = 1.05; 95% CI, 1.01Y1.09). Conclusion: Male practitioners marginally outperformed their female counterparts in ambulatory practices enrolled in a voluntary cardiovascular performance improvement registry program. Overall low adherence to some performance measures suggests room for improvement among all practitioners.
explain the gaps in adherence to guidelines. 5Y7 However, few studies have examined the relationship between practitioner factors, such as practitioner gender and quality of care in ambulatory cardiology practices.
The extent to which practitioner gender is associated with differences in the quality of ambulatory care is debated. Several studies suggest that women practitioners are more likely to provide guideline-concordant care. 8Y14 In contrast, other studies have found no differences in the quality of cardiovascular risk management between women and men practitioners. 15 Reasons for these conflicting findings may be related to the limitations in study designs including the use of regional cohorts, the use of cross-sectional design, or an inability to account for visit frequency or exclude patients who are ineligible for a particular treatment. Few studies have specifically looked at the role of practitioner gender in the quality of ambulatory cardiology care. 14 Accordingly, we examined the association between practitioner gender and the quality of ambulatory cardiology care, as quantified by adherence to established disease-specific performance measures, among outpatient cardiology clinics that participate in the American College of Cardiology"s Practice Innovation and Clinical Excellence (PINNACLE) Registry. We specifically assessed the performance measures for eligible patients with coronary artery disease (CAD), heart failure due to left ventricular systolic dysfunction (LVSD), and atrial fibrillation (AF). Understanding the potential association of practitioner gender with adherence to performance measures may inform targets for interventions aimed at improving the quality of ambulatory cardiology care.
Methods

Data Source
The National Cardiovascular Data PINNACLE Registry consists of consecutive patients from cardiology practices in the United States who voluntarily submit data as part of a national office-based cardiovascular quality improvement program. 16, 17 The data are collected at the point of care using a validated electronic medical record mapping algorithm for patients with hypertension, CAD, heart failure with LVSD, and AF. 18, 19 Registry data quality is maintained through data definitions, standard data collection and transmission, and periodic data quality checks.
18Y20
Study Population
All patients enrolled in the PINNACLE program with at least 1 outpatient visit with a unique male or female practitioner from 2008 to 2012 were considered for inclusion. To include visits in which the treating practitioner had prescribing authority, only visits with either a physician (doctor of medicine or doctor of osteopathic medicine) or an advanced practice practitioner (nurse practitioner or physician assistant) were included. Patients were excluded if they saw more than 1 practitioner over the study interval. Finally, the patients were excluded if there were missing data on practitioner gender or practitioner type.
For each performance measure of interest, patients were included in the analysis only if they met eligibility criteria for that particular performance measure. Patients were excluded for individual performance measures if they had a documented contraindication to that particular therapy (eg, "-blocker use after myocardial infarction in a patient with hypotension, patient preference to not take oral anticoagulation for AF).
Predictor Variables
The primary predictor of interest was the treating practitioner"s gender. For each patient visit, the National Practitioner Identifier number of the treating practitioner was collected at the point of care. The National Practitioner Identifier number was searched within the National Plan and Practitioner Enumeration System database to identify the practitioner"s gender and practitioner category (physician or advance practice practitioner). 21 
Outcomes
Among eligible patients, adherence with 7 American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association -Physician Consortium for Performance Improvement performance measures for CAD (n = 4), heart failure due to LVSD (ejection fraction e40%) (n = 2), and nonvalvular AF with high thromboembolic risk (n = 1) were determined. The performance measures examined included (1) use of "-blockers after previous myocardial infarction, (2) use of lipid-lowering drug in patients with CAD, (3) use of antiplatelet therapy in patients with CAD, (4) angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) therapy for patients with CAD and either LVSD (ejection fraction e40%) or diabetes mellitus, (5) "-blocker therapy for patients with heart failure and LVSD, (6) ACEI or ARB therapy for patients with heart failure and LVSD, and (7) warfarin or non-vitamin K oral anticoagulants therapy in patients with AF and a CHADS2 score of 2 or higher. 22 For each practitioner, adherence was defined as the number of their patients who met the performance measure over the study interval divided by the practitioner"s total number of eligible patients for that performance measure. The study interval began with a patient"s first visit noted in the PINNACLE Registry and ended 12 months later. Therefore, a practitioner was considered adherent for a particular patient if that patient fulfilled the performance measure at any visit over the 12-month study period.
Statistical Analyses
Patient demographic and clinical characteristics were compared between those treated by male and female practitioners using # 2 or Fisher"s exact tests for categorical variables and student t test for continuous variables.
In the primary outcomes analysis, adherence rates for each of the 7 performance measures were compared between female and male practitioners. To assess the association between physician gender and adherence rate, we constructed 3-level hierarchical models (with patients nested within practitioners and practitioners nested within clinic sites) adjusted for practitioner category (physicians or advanced practice practitioners) and number of total visits over 1-year follow-up. In these models, modified Poisson models were used to estimate rate ratio (as opposed to an odds ratio obtained from logistic model) because treatment rates exceeded 10%. 23, 24 All analyses were performed with SAS version 9.3 (SAS Institute, Cary, North Carolina).
Results
Study Cohort
Patients A total of 1 045 711 patients enrolled in PINNACLE (cared for by 1613 practitioners) were eligible for at least 1 of the 7 examined performance measures and considered for inclusion. Among these patients, 262 347 (25%) were excluded for reasons shown in Figure 1 . Our final study cohort comprised 769 139 patients cared for by 1493 unique practitioners (Figure 1 ).
Practitioner Characteristics
Of the final study cohort, 1193(80%) were men, and 300 (20%) were women. Male practitioners were more likely to be physicians compared with female practitioners (1172 [98% of male practitioners] vs 131 [44% of female practitioners], P G .01).
Patient Level Characteristics by Practitioner Gender
Most patients in the cohort (n = 702 726, 91%) saw male practitioners. Patients who saw a male practitioner were slightly older, were more often male, and had a higher prevalence of CAD. The mean number of visits over the 12-month study period was slightly higher for male compared with female practitioners (2.22 T 1.5 vs 2.17 T 1.5, P G .01) (See Table, 
Adherence With Performance Measures by Practitioner Gender
In unadjusted analysis stratified by practitioner gender, male practitioners had higher adherence rates to 6 of the 7 examined performance measures compared with female practitioners (Table) . In eligible patients with LVSD, the adherence rates for male practitioner was higher than the adherence rates for female practitioners for ACEI/ARB therapy with no statistically significant difference by practitioner gender for "-blocker use. Adherence rates to oral anticoagulant use in eligible patients with AF were higher in male practitioners compared with female practitioners (Table) .
After adjustment for practitioner type and number of clinic visits, male practitioners had persistently higher adherence with 4 of the 7 performance measures ( Figure 2 ). Compared with female practitioners, male practitioners were statistically more likely to prescribe antiplatelet "-blocker therapy lowering therapy for patients with CAD and oral anticoagulants for patients with AF.
Discussion
Among this cohort of ambulatory cardiology practices participating in the PINNACLE Registry, overall adherence rates for the CAD, heart failure, and AF guidelinebased performance measures varied from 49% to 91%. When considering practitioner gender, adherence rates with 3 of the 7 performance measures were similar between male and female practitioners after adjustment for practitioner category and number of clinic visits. Relative to female practitioners, male practitioners were marginally more adherent (absolute difference, 4%-8%) with prescribing therapy for CAD and AF. These findings suggest that, although overall adherence rates to some performance measures remains low, there was little difference in adherence to performance measures between male and female cardiology practitioners treating patients in the ambulatory setting.
Similar to other studies, our findings suggest that overall adherence to many performance measures remains low. In a study by Chan et al 4 using an earlier cohort within PINNACLE, adherence with performance measures ranged from 70% to 90%. Specifically, the adherence for heart failure performance measures was similar to our own; however, adherence to oral anticoagulants in AF and medical therapies in CAD were higher than in our study. 4 Our rates of oral anticoagulants use are similar to recent international studies that have shown adherence rates between 50% and 60%. 25, 26 Therefore, adherence rates to some performance measures remains low and suggest continued room for quality improvement.
Overall, the results of our study do not suggest significant differences in adherence to performance measures based on practitioner gender. Disparities in care based on practitioner gender and its effect on health care processes have been investigated in smaller studies in primary care, obstetrics, gynecology, and surgery. A recent study by Tsugawa et al 27 demonstrated that hospitalized Medicare patients cared for by female internists had lower rates of hospital mortality and readmission compared with those cared for by male internists. Mechanisms proposed for the differences in guidelineconcordant care between male and female practitioners include differences in communication style, decisionmaking approaches, and length of time spent with patients. 12, 14, 27 Contrary to previous studies, we found that female practitioners have slightly lower adherence rates than male practitioners on some performance measures. However, the absolute differences in our study were small (range, 4%Y8%) and less than the previous reports of performance differences among male and female primary care practitioners (range, 14%Y16%). Therefore, our findings suggest that practice patterns of cardiology practitioners may not vary as greatly by practitioner gender as those seen in primary care settings.
An important difference between ambulatory cardiology practices and primary care practices is the small number of women practitioners in cardiology. 28 Only 20% (n = 300) of the overall sample of practitioners in our study were women, which is comparable to national estimates of women in cardiology. 29, 30 Furthermore, only 44% of the female practitioners in our study were physicians, compared with 98% of male practitioners. Even though women comprise close to half of medical school classes, only 12% of general cardiologists and less than 10% of interventionalists and electrophysiologists are women. 31 Therefore, the overall number of women practitioners, particularly women physicians, in our study was small, and future studies with larger numbers of women practitioners are needed.
Our study addresses limitations of previous work by including a robust, nationally representative sample of cardiology patients who met predefined eligibility criteria for each performance measure. Furthermore, we were able to adjust for practitioner type and the number of office visits over the course of follow-up. Finally, the data in PINNACLE were not limited to a single disease entity or diagnosis and therefore represents multiple cardiovascular disease states commonly encountered in outpatient cardiology practice. Therefore, we were able to examine whether any gender differences found were common across many different diagnosis, suggesting an overall pattern of care. Taken together, our findings suggest that, among eligible patients, there is little difference in adherence to performance measures by practitioner gender across a wide range of cardiology conditions.
The results of our study should be interpreted in light of a few limitations. First, participation in PINNACLE is voluntary, and highly motivated practices may be over represented. However, there is no reason to believe that potential practitioner gender differences would necessarily differ among participating and nonparticipating clinics. Second, underdocumentation, as opposed to true underperformance, may explain the suboptimal rates of selected performance measures. However, PIN-NACLE data are pulled directly from the electronic health record from medications ordered, patient problem lists, and diagnostic codes. Because these fields are widely used by health systems for quality tracking and billing purposes, we would expect that the incentives to enter complete information are similar for male and female practitioners. Third, because there were baseline differences in patient clinical characteristics among those seen by male versus female practitioners, differences in the patient complexity may have confounded the relationships found. Finally, our study may be underpowered to detect true gender differences given the small proportion of female practitioners. Our cohort had small numbers of female physicians (n = 131, 44% of female practitioners) and male advanced practice practitioners (n = 21, 2% of male practitioners); therefore, we are unable to examine whether the differences found significantly vary by practitioner type. These findings should be replicated in larger cohorts that include greater variation by practitioner gender and type.
Conclusion
Male practitioners slightly outperformed female practitioners" adherence to 4 of 7 performance measures in ambulatory cardiology practices within this large national registry. However, the absolute differences in performance were small (4%Y8%), suggesting that practice patterns among cardiology practitioners may not vary as greatly by practitioner gender as those seen in other settings. Importantly, overall adherence to some performance measures was low for both male and female practitioners, suggesting room for improvement among all practitioners. Our findings merit confirmation in future studies among larger cohorts of practitioners in varied clinical settings. 
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